Consent to the Distribution of a New Medicine
In the notice published in the New Zealand Gazette, 26 July 2001, Issue No. 77, page 1842, delete the entry for Mylanta P and replace with the following entry:
Product: Mylanta P
Active Ingredient(s): Aluminium hydroxide 40mg/mL
Magnesium hydroxide 40mg/mL
Simethicone 4mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Warner Lambert Consumer Group Div. of Pfizer Laboratories Limited
Manufacturer(s): Parke Davis Pty Limited, Caringbah, Sydney, New South Wales, Australia
Dated this 31st day of July 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).